Jun 1, 2026 07:01AM
Jun 1, 2026 07:00AM
May 26, 2026 08:00AM
May 26, 2026 08:00AM
May 15, 2026 04:30PM
May 15, 2026 04:30PM
May 5, 2026 08:00PM Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization
Apr 29, 2026 08:00AM
Apr 24, 2026 04:30PM
Apr 24, 2026 04:30PM
Apr 24, 2026 08:00AM
Apr 24, 2026 08:00AM
Mar 31, 2026 09:13AM
Mar 31, 2026 09:11AM Citius Oncology Provides Commercial Update on LYMPHIR™ Launch Highlighting Early Adoption and Expanding Clinical Development
Mar 24, 2026 08:00AM
Mar 10, 2026 08:47AM
Mar 10, 2026 08:47AM
Mar 4, 2026 09:15AM
Mar 4, 2026 09:15AM
Feb 24, 2026 08:00AM
Feb 13, 2026 08:00AM Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
Feb 13, 2026 08:00AM
Feb 11, 2026 08:02AM
Feb 11, 2026 08:00AM
Dec 23, 2025 04:31PM
Dec 23, 2025 04:30PM
Dec 23, 2025 04:30PM
Dec 10, 2025 04:30PM Citius Oncology closes $18 million stock offering at $1.09 per share
Dec 10, 2025 04:30PM
Dec 9, 2025 08:30AM
Dec 9, 2025 08:30AM
Dec 4, 2025 08:37AM
Dec 4, 2025 08:37AM
Dec 1, 2025 12:08PM
Dec 1, 2025 12:00PM Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
Nov 25, 2025 08:00AM
Nov 21, 2025 08:37AM
Oct 21, 2025 04:30PM
Oct 21, 2025 04:30PM
Oct 21, 2025 08:01AM
Oct 21, 2025 08:00AM
Oct 20, 2025 08:38AM Citius Oncology signs distribution deal with McKesson for LYMPHIR launch
Oct 20, 2025 08:37AM
Oct 17, 2025 05:00PM
Oct 16, 2025 08:47AM
Oct 16, 2025 08:47AM
Oct 7, 2025 08:47AM
Sep 10, 2025 04:30PM
Sep 10, 2025 04:30PM Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
Sep 9, 2025 08:30AM

323,592 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All